Former Federal Trade Commissioner Pamela Jones Harbour is a partner in Fulbright & Jaworski L.L.P.’s antitrust and competition practice. Pamela heads the firm's Privacy, Competition and Data Protection practice group. She is well recognized for her knowledge of evolving areas of competition and consumer protection law, including privacy and data security issues.
Pamela served on the Federal Trade Commission from 2003 until April 2010. Prior to serving on the Commission, Pamela was an antitrust partner at a New York firm. She previously spent a decade working in the New York Attorney General’s Office, including as Deputy Attorney General, where she investigated and prosecuted a variety of antitrust and consumer protection violations.
During her nearly seven years as a Commissioner, Pamela was instrumental in shaping an ambitious Federal Trade Commission agenda that encompassed a wide variety of competition and consumer protection issues affecting virtually every economic sector. Before joining the FTC, Pamela successfully prosecuted numerous national price-fixing conspiracies as a top litigator in the New York Attorney General's office, including serving as lead counsel in several multi-state cases and arguing a resale price maintenance (RPM) case, State Oil v. Khan, on behalf of 35 states before the U.S. Supreme Court. During that time, Pamela was chief of the Office's 150-attorney Public Advocacy Division.
Pamela is recognized internationally for her leadership in the emerging field of privacy and data security. She was the 2010 recipient of the Electronic Privacy Information Center’s (EPIC’s) “Champion of Freedom Award” for her defense of consumer privacy as an FTC Commissioner. As a key member of the U.S. delegation to the Asia Pacific Economic Cooperation (APEC) summits, she was directly involved in representing U.S. interests during negotiation and future implementation of a global privacy framework related to cross-border data transfers. Beyond her contributions in the realm of information practices, Pamela also has played an important role in shaping the legal discourse on technological standard setting, innovation markets, vertical distribution restraints, pharmaceuticals and biotechnology and health care.
